Novartis and Massachusetts Institute of Technology (MIT) in new partnership aimed at transforming pharmaceutical manufacturing
* Novartis to invest USD 65 million in MIT research to develop new technologies for continuous manufacturing, from chemical synthesis to final product
01-Oct-2007 -
Novartis and the Massachusetts Institute of Technology have launched a long-term research collaboration aimed at transforming the way pharmaceuticals are produced.
The 10-year partnership, known as the Novartis-MIT Center for Continuous Manufacturing, will work to develop new technologies that ...
chemical synthesis
industrial balances
laboratories
+3